Pacritinib in Vacuoles, E1 Ubiqutin-activating Enzyme, X-linked, Autoinflammatory, Somatic (VEXAS) Syndrome
Clinical trial NCT06538181 · RECRUITING
Trial details
- NCT number
- NCT06538181
- Sponsor
- Washington University School of Medicine
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-13
- Primary completion
- 2027-03-31
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.